Related by context. Frequent words. (Click for all words.) 73 Overactive Bladder 71 Peripheral Artery Disease 70 Ischemic 69 Benign Prostatic Hyperplasia 69 Diabetic Retinopathy 69 Pulmonary Arterial Hypertension 69 Phase III Clinical Trial 68 Clinical Trial Results 68 Peripheral Arterial Disease 68 Pivotal Trial 67 Heart Failure Patients 67 Phase III Trial 66 Chronic Heart Failure 66 Metastatic Melanoma 66 Diabetic Patients 65 Pivotal Phase III 65 Diabetic Macular Edema 65 Atopic Dermatitis 65 Patient Enrollment 65 Completes Enrollment 65 Rheumatoid Arthritis RA 65 Pivotal Phase 65 Occlusion 65 Allergic Rhinitis 65 Drug Candidate 64 Metastatic Colorectal Cancer 64 Ischemia 64 Patients Treated 64 Urinary Incontinence 63 Breast Cancer Treatment 63 Irritable Bowel Syndrome IBS 63 Psoriatic Arthritis 63 Bladder Cancer 63 Chronic Lymphocytic Leukemia 63 Aliskiren 63 Esophageal 63 FDA Clears 63 critical limb ischemia 62 Carotid 62 intermittent claudication 62 Elderly Patients 62 Acute Myocardial Infarction 62 Insulin Resistance 62 Gum Disease 62 Non Invasive 62 Thrombocytopenia 62 retinal vein occlusion 62 Drug Eluting Stents 62 Neuropathic Pain 62 Dyslipidemia 62 SHPT 62 Prostate Cancer Patients 61 juvenile idiopathic arthritis 61 Fibrosis 61 Solid Tumors 61 Advanced Prostate Cancer 61 Preclinical Data 61 Autoimmune Diseases 61 Congestive Heart Failure 61 Combination Therapy 61 Soft Tissue 61 Kidney Stones 61 Major Depressive Disorder 61 Alemtuzumab 61 Hepatitis C Virus 61 Drug Eluting Stent 61 Autologous 61 Significantly Reduces 61 Ventricular 61 Prostate Cancer Treatment 61 Retinopathy 61 secondary hyperparathyroidism 60 Rheumatoid Arthritis 60 Early Diagnosis 60 Mild Cognitive Impairment 60 C Reactive Protein 60 Cardiac Resynchronization Therapy 60 Cancer Treatments 60 Receives FDA Clearance 60 gastrointestinal stromal tumors GIST 60 Ablation 60 Resection 60 FDA Clearance 60 Bevacizumab 60 tumor lysis syndrome 60 Acute Coronary Syndrome 60 Pulmonary Hypertension 60 Blood Clots 60 Obstructive Sleep Apnea 60 peripheral arterial disease 60 Monotherapy 60 Cataract Surgery 60 Presents Positive 60 Natalizumab 60 Well Tolerated 59 Restless Legs Syndrome 59 Drug Resistant 59 Percutaneous Coronary Intervention 59 Periodontitis 59 Dasatinib 59 Ulcerative Colitis